TRAGBARE ARZNEIABGABEVORRICHTUNG
European patent · EP3928813 · In force
Register entry
- Publication number
- EP3928813
- Application number
- EP20181602
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jun 23, 2020
- Published
- Dec 29, 2021
- Granted
- May 14, 2025
- Protection ends at the latest
- Jun 22, 2040
- Next annual fee due
- Jun 30, 2027
- IPC classes
- A61M 5/142 (2006.01)
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jul 1, 2026
Next annual fee due on
- Next annual fee due on
- 30.06.2026 → 30.06.2027
Published in Swissreg on 01.07.2026
- Mar 25, 2026
Change
Published in Swissreg on 25.03.2026
- Mar 10, 2026
Transferred
- Owner
- TecMed AG, Technikumstrasse 2, 3400 Burgdorf → mylife Diabetes Care AG, Lyssachstrasse 40, 3400 Burgdorf
- Representative
- IP Abteilung -mylife Diabetes Care AG, Lyssachstrasse 40, 3400 Burgdorf
Published in Swissreg on 10.03.2026
- Aug 5, 2025
Next annual fee due on
- Next annual fee due on
- 30.06.2025 → 30.06.2026
Published in Swissreg on 05.08.2025
- May 14, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 14.05.2025
Parties
Inventor
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.